These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 301779)

  • 21. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
    Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL
    Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM; Zaharko DS; Bull JM; Chabner BA
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.
    DeSesso JM; Goeringer GC
    Teratology; 1991 Mar; 43(3):201-15. PubMed ID: 2014483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
    Rhee MS; Coward JK; Galivan J
    Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acid.
    Hart BP; Haile WH; Licato NJ; Bolanowska WE; McGuire JJ; Coward JK
    J Med Chem; 1996 Jan; 39(1):56-65. PubMed ID: 8568827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and pharmacologic rationale for high-dose methotrexate.
    Jolivet J
    NCI Monogr; 1987; (5):61-5. PubMed ID: 2448656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
    Motycka K; Slavík K; Balcarová A; Spacek P; Kubín M
    Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of folate compounds on the accumulation of methotrexate and the activity of dihydrofolate reductase in liver, kidney and small intestine of the mouse.
    Rothenberg SP; Iqbal MP; da Costa M
    J Pharmacol Exp Ther; 1982 Dec; 223(3):631-4. PubMed ID: 6982970
    [No Abstract]   [Full Text] [Related]  

  • 32. Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
    May C; James RI; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1444-51. PubMed ID: 8819532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronotoxicity of methotrexate in mice after intraperitoneal administration.
    Labat C; Mansour K; Malmary MF; Terrissol M; Oustrin J
    Chronobiologia; 1987; 14(3):267-75. PubMed ID: 3677924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
    Sadée W
    Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A radioimmunoassay for methotrexate and its comparison with spectrofluorimetric procedures.
    Loeffler LJ; Blum MR; Nelsen MA
    Cancer Res; 1976 Sep; 36(9 pt.1):3306-11. PubMed ID: 1086132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI; May C; Vagt MD; Studebaker R; McIvor RS
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.